• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study Webcast

    Credits

    1 Contact Hour(s)

    Release Date

    Tuesday, September 5, 2017

    Offline Date

    Monday, March 5, 2018

    ACPE Expiration Date

    Sunday, July 5, 2020

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $0.00

    • Overview

      Many people have a difficult time with bowel movements. Because so many patients self-treat the condition, estimates of the number of Americans that suffer from chronic idiopathic constipation vary widely but the National Institute of Health estimates that 42 million people are afflicted with constipation. Despite the $400 million dollars that are spent on laxatives each year, constipation still accounts for 2.5 million physician visits annually in the U.S. revealing a desperate need for improved patient counseling and knowledge of pharmacologic options beyond laxatives in pharmacies around the nation where millions of patients seek pharmacist recommendations. When traditional treatments, such as dietary manipulation and standard laxatives do not adequately treat or fail to treat CIC, pharmacists must be prepared to educate patients regarding the pharmacologic options available to relieve this frustrating and costly condition.

      Rating

         4.50  out of 5

      Handouts

      • Slide Document :   0798000017113H01_4pp.pdf
      • Slide Document :   0798000017113H01_2pp.pdf

      Financial Support By

      Synergy Pharmaceuticals Inc.
    • Pharmacist

      Describe the impact and economic burden of CIC in the U.S.
      Review the FDA approved pharmacologic treatment options for CIC beyond laxatives, to include novel targets, efficacy data, primary contraindications, and adverse effects.
      Outline the pharmacist’s role in identifying inadequately treated patients and providing patient counseling regarding prescription treatment options that will facilitate communication with the physician.

      Pharmacy Technician

      Recognize prescription medications available to treat constipation not adequately treated by laxatives and dietary measures
      Identify first line treatments for constipation
      Describe the impact and economic burden of CIC in the U.S

      Nurse

      Outline the pharmacist’s role in identifying inadequately treated patients and providing patient counseling regarding prescription treatment options that will facilitate communication with the physician.
      Review the FDA approved pharmacologic treatment options for CIC beyond laxatives, to include novel targets, efficacy data, primary contraindications, and adverse effects.
      Describe the impact and economic burden of CIC in the U.S.
    • Activity Type

      Knowledge

      CE Broker

      20-574633

      Universal Activity Number

      Pharmacist 0798-0000-17-113-H01-P
      Pharmacy Technician 0798-0000-17-113-H01-T
      Nurse 0798-0000-17-113-H01-P

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).